Thursday, 9 April 2009

Lanthanum Carbonate (Fosrenol) Chewable tablets 500 mg, 750 mg and 1gm: Natco and Lupin to jointly commercialize generic version

This post is in continuation to our earlier post Here, the first Para IV filer Natco has collaborated with M/S Lupin, to jointly commercialize generic version of Lanthanum Carbonate (Fosrenol) Chewable tablets 500 mg, 750 mg and 1gm

Link to business-standard news Here

No comments:

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker